Related Experiment Video
Updated: Mar 13, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time
Ibrahim F Shatat1, Suparna Qanungo2, Shannon Hudson2
1Pediatric Nephrology and Hypertension, Sidra Medical and Research Center, Doha, Qatar; College of Nursing, Medical University of South Carolina, Charleston, SC, USA; Weill Cornell Medical College, New York, NY, USA.
Insights
Microalbuminuria (MA) in children with sickle cell disease (SCD) can fluctuate over time. Age and bilirubin levels predict MA increase in transfused patients, highlighting the need for further renal injury research.
Area of Science:
- Pediatric Nephrology
- Hematology
- Sickle Cell Disease Research
Background:
- Microalbuminuria (MA) affects approximately 20% of children with sickle cell disease (SCD).
- Limited data exists on the progression of MA in pediatric and young adult SCD populations.
- MA is recognized as an early indicator of renal injury in this demographic.
Purpose of the Study:
- To analyze the progression of microalbuminuria in children and young adults with SCD.
- To determine the rate, direction, magnitude, and predictors of microalbuminuria-to-creatinine (MA/Cr) ratio changes over a 5-year period.
- To investigate factors influencing MA/Cr fluctuations in pediatric SCD patients.
Main Methods:
- Retrospective analysis of 5-year electronic medical record (EMR) data.
- Inclusion of 373 children with SCD and at least two MA/Cr ratio measurements.
- Utilized multivariate logistic regression to identify predictors of MA/Cr change.
Main Results:
- Of 45 children with baseline MA, 47% persisted with MA, while 24 new cases developed and 24 normalized during follow-up.
- Age and bilirubin levels were significant predictors of MA/Cr increase in patients receiving blood transfusions.
- Initial MA level was not a predictor of subsequent MA/Cr change.
Conclusions:
- Microalbuminuria levels in children and young adults with SCD can increase or decrease over time.
- Further research is essential to validate MA as a long-term renal injury marker in SCD.
- Identifying high-risk individuals for worsening MA is crucial for proactive management.
Background:
Approximately 20% of children with sickle cell disease (SCD) have microalbuminuria (MA). Very little is known about the progression of MA in children and young adults with SCD.
Methods:
In this study, we analyzed 5-year EMR data of 373 children [with ≥2 microalbumin-to-creatinine (MA/Cr) ratio measurements] followed at the Medical University of South Carolina to determine the rate, direction, magnitude, and predictors of MA/Cr change over time.
Results:
Age range was 1-22 years; mean 10.2 ± 5.2 years, 49.5% were males. Median follow-up duration was 3.12 ± 1.16 years. At baseline, 328 children had normal (<20 mg/L) MA level. Forty-five (12.1%) of children had MA (≥20 mg/L), of which 91% were ≥8 years and 21 (47%) continued to have MA at the end of the study period. On the other hand, during the study period, 24 new patients developed MA and 24 normalized their MA to levels <20 mg/L. In multivariate logistic regression model, age and bilirubin levels were predictive of MA/Cr increase in patients who received at least one blood transfusion during the study period. Baseline MA level was not predictive of the change in MA/Cr.
Conclusion:
In children and young adults, microalbuminuria is considered a marker of early renal injury. Over time, MA/Cr levels may increase or decrease. Further studies are needed to confirm our findings, assess the reliability of MA as marker of long-term renal injury, and identify high risk patients with SCD likely to have worsening of MA over time.
Related Concept Videos
Serum Studies: Renal Function Tests
Urine Studies I: Urinalysis
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management

